NOVELTY – An inclusion compound between beta cyclodextrin and praziquantel (PZQ) has increase in the solubility of commercial PZQ and thus of the bioavailability of antiparasite agent. The controlled release of the drug impedes attainment of high plasmatic levels.
C07 (Apparatus, formulation, general. including veterinary syringes, general formulations where the active compound is not central to the invention (e.g. wettable powders) and analysis.)